Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Turkey’s Top Defense Company Sets Sights On Medical Technology

Executive Summary

Aselsan, Turkey's leading defense company, is increasing its focus on medical technology to support localization of medical devices. The company has started projects to develop and produce mobile X-ray and MRI systems, as well as defibrillators.

You may also be interested in...

Turkish Government Changes Model For Giant Device Tender To Enable Local Company Bids

As the date for multibillion-dollar medical device bidding process for hospitals in Turkey gets closer, the government made an important change, dropping the condition that bids must cover the whole package of requested devices. This opens the way for partial bids that smaller companies might be able to handle.

Another Postponement Of Turkish Medical Device Tender Raises Eyebrows

The Turkish Government postponed a $10bn medical device tender for at least the third time, to January 10. But it is the government's insistence that the giant tender will go on at all, rather than be canceled outright, that has attracted criticism from local companies, who object to some of the tender's conditions.

Giant Turkish Medical Device Tender Postponed Again

A big tender for advanced imaging and patient monitoring devices originally had been scheduled by the Turkish Government for July 4, but it has been postponed, now for a third time, with the date set for October 31. The procurement effort, with an estimated value of about $10bn, is intended to furbish new city hospitals with locally produced high-tech medical devices, but it has been the target of controversy, and there are some speculations that it might be canceled.


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts